References in periodicals archive ?
BARCELONA, Spain, May 11 /PRNewswire/ -- SALVAT have announced plans to file their CETRAXAL Otic solution, with Its convenient, single-dispensing container (SDC) format, with the FDA.
BARCELONA, Spain -- SALVAT announced that the New Drug Application (NDA) for its CETRAXAL Otic -ciprofloxacin otic- 0.
CETRAXAL Otic, in a single dispensing container, will be the only ciprofloxacin alone solution approved by the FDA for the indication of external otitis, providing high efficacy and more convenience without the risk of steroids, aminoglycosides and preservatives.
BARCELONA, Spain, April 20 /PRNewswire/ -- SALVAT announce plans to file their CETRAXAL Otic solution, with its convenient, single-dispensing container (SDC) format, with the FDA.
BARCELONA, Spain -- SALVAT today announced that it has submitted a new drug application for their CETRAXAL Otic solution, with its convenient, single-dispensing container (SDC) format, with the FDA.
BARCELONA, Spain -- SALVAT announce plans to file their CETRAXAL Otic solution, with its convenient, single-dispensing container (SDC) format, with the FDA.
BARCELONA, Spain, April 18 /PRNewswire/ -- SALVAT announce plans to file their CETRAXAL Otic solution, with its convenient, single-dispensing container (SDC) format, with the FDA.
CETRAXAL eardrops (currently under US-FDA review) and by emphasizing collaborations regarding its pipeline products.
BARCELONA, Spain, June 10 /PRNewswire/ -- SALVAT today announced that it has submitted a new drug application for their CETRAXAL Otic solution, with its convenient, single-dispensing container (SDC) format, with the FDA.